Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$43.41 USD

43.41
778,573

+0.91 (2.14%)

Updated May 6, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (142 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for QDEL

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

QuidelOrtho Corporation [QDEL]

Reports for Purchase

Showing records 161 - 180 ( 184 total )

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 161

03/21/2011

Daily Note

Pages: 12

Week 10 Flu Update; Flu Decline Continues as Expected; Orders Likely Good Until End of Q; Still Not Excited About Shares

Provider: WEDBUSH SECURITIES INC.

Analyst: KIDD W

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 162

03/02/2011

Company Report

Pages: 11

4Q10 Results Ok; Average Flu Slated for 2011, Lacking Needle Movers and Leverage; Downgrading to NEUTRAL and Lowering PT to $13

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 163

02/21/2011

Company Report

Pages: 7

4Q10 Likely Uneventful; Refining PT Lower Until Better EPS Visibility; No Obvious Near Term Catalysts

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 164

01/06/2011

Company Report

Pages: 8

4 MM Share Offering Confusing

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 165

01/03/2011

Company Report

Pages: 10

Week 51 Flu Update; Widespread Flu Activity and ILI Rate Up Substantially Wk/wk, Order Spigot.

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 166

12/20/2010

Company Report

Pages: 8

Flu Update; Total Flu Cases Down Slightly Wk/wk, But Uptick

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 167

12/06/2010

Company Report

Pages: 9

Flu Update; Steady Increase Continues; Uptick in ILI Rate Is Encouraging

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 168

11/30/2010

Company Report

Pages: 9

Flu Update; Influenza Cases and US Statewide Activity Up Wk/wk

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 169

11/22/2010

Company Report

Pages: 9

Flu Update; Total Levels Light But Uptick Continues; Reaffirming OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 170

11/15/2010

Company Report

Pages: 9

Flu Update; Slight Wk/wk Uptick in Flu Activity; Reaffirming OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 171

11/09/2010

Company Report

Pages: 9

Introducing the Wedbush Flu Update; Activity Remains Light Worldwide; Distributor Inventory Still Manageable

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 172

10/28/2010

Company Report

Pages: 7

Lackluster 3Q10 as We Expected

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 173

10/26/2010

Company Report

Pages: 4

3Q10 Financial Preview; Expecting Messy Quarter But Stock Unlikely to Be Impacted; Investors Still Focused on 2011

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 10.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 174

10/04/2010

Company Report

Pages: 4

Playing Chicken with Distributors; Lowering Estimates as Non-Promotional Selling Plays Out.

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 10.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 175

08/17/2010

Industry Report

Pages: 13

MEDTECH TECHNICAL PAIR TRADE IDEAS

Provider: CAPSTONE INVESTMENTS

Analyst: SINE B

Price: 50.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 176

08/04/2010

Industry Report

Pages: 15

Life Sciences -MAC Best Ideas Conference - Key Takeaways New York City.

Provider: WEDBUSH SECURITIES INC.

Price: 50.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 177

07/30/2010

Company Report

Pages: 7

2Q10 Lighter on Absence of Flu Sales; Op Ex Kept Under Control; Many Irons in the Fire Still for 2011; Reaffirming OUTPERFORM.

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 178

07/27/2010

Company Report

Pages: 5

2Q10 Preview: Bringing Down Estimates In Light of Uninspiring VIVO, DGX, BEC, & TMO Results; Remain Positive Long Term

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 10.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 179

06/08/2010

Company Report

Pages: 10

Shares Revisiting 52 Week Low; Reiterating OUTPERFORM; - Greater Sell-Off Tees Up Easier Flu Trade; Fundamentals Ok

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party

Company: QuidelOrtho Corporation

Industry: Medical - Products

Record: 180

05/27/2010

Company Report

Pages: 11

Selloff Overdone; Upgrading to OUTPERFORM from NEUTRAL on Improved Risk/Reward for Next Flu Cycle; Resetting Estimates in the Process; Week 19 Flu Levels Weak As Usual.

Provider: WEDBUSH SECURITIES INC.

Analyst: KHURSHID Z

Price: 25.00

Research Provided by a Third Party